loader image
Wednesday, November 19, 2025
90 F
McAllen
- Advertisement -

COVID-19 statistics expert from Harvard to speak at UTRGV during virtual event

Translate to Spanish or other 102 languages!

Dr. Xihong Lin, from Harvard’s Department of Biostatistics, will speak on “Learning from COVID-19 Data on Transmission, Health Outcomes, Interventions and Vaccinations” on March 19 during a UTRGV virtual colloquium. (Courtesy Photo)

Mega Doctor News

- Advertisement -

By Karen Villarreal

RIO GRANDE VALLEY, TEXAS – A Harvard University expert on COVID-19 statistics and data will be the distinguished speaker March 19 at a UTRGV virtual colloquium. The UTRGV School of Mathematical and Statistical Sciences (SMSS), which hosts the annual colloquium, is hosting the lecture, which is free and open to the public via Zoom link.

Dr. Xihong Lin, from Harvard’s Department of Biostatistics, will speak on “Learning from COVID-19 Data on Transmission, Health Outcomes, Interventions and Vaccinations.”

- Advertisement -

The lecture will focus on data that show the effects of public health interventions on controlling the COVID-19 outbreak, such as social distancing, isolation and quarantine. She also will discuss statistical analysis of the demographic, social-economic and comorbidity factors associated with COVID-19.

An elected member of the National Academy of Medicine, Lin also is an associate member of the Broad Institute of MIT and Harvard, a biomedical and genomic research center.She will explain how transmission rates are estimated using statistical models and explain the results of some studies. One study, with more than 500,000 participants of the “HowWeFeel project,” asked about behavior and vaccine hesitancy. Another study looked at confirmed cases in Wuhan, China, to estimate transmission rates.

UTRGV SMSS professor Dr. Bao-Feng Feng will introduce Lin. He and Dr. Tamer Orabywill invite Lin to engage in a question and answer session after her presentation.

The SMSS Colloquium is an annual event that brings experts in the areas of mathematics and statistics from other institutions to UTRGV to exchange research ideas with UTRGV students and faculty. The lecture will begin at 11:30 a.m. Friday, March 19, 2021, via Zoom:https://utrgv.zoom.us/j/84780642513

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Paxton Secures $41.5M from Pfizer & Tris Pharma for Providing Adulterated Drugs to Children

Attorney General Ken Paxton has secured a $41.5 million settlement with Pfizer and Tris Pharma for allegedly providing adulterated pharmaceutical drugs to Texas children in violation of the Texas Health Care Program Fraud Prevention Act (“THFPA”).    

STHS’ South Texas Healthy Living Episode on Diabetes Awareness, Nov. 30th

The United States is experiencing a national health crisis as the incidence of diabetes continues to climb across the country.

DHR Health Encourages Early Detection with $99 Lung Cancer Screening Special Thru Dec. 31st

Lung cancer remains the leading cause of cancer death in the United States, accounting for about one in five cancer deaths nationwide. According to the American Cancer Society, an estimated 226,650 new cases of lung cancer will be diagnosed in 2025, and 124,730 people are expected to die from the disease. Each year, lung cancer claims more lives than colon, breast, and prostate cancers combined.

Aesculap Implant Systems Settles for $38.5M, Enters Non-Prosecution Deal

Medical device company Aesculap Implant Systems LLC (Aesculap), based in Center Valley, Pennsylvania, has agreed to pay $38.5 million to resolve allegations under the False Claims Act that the company sold knee replacement devices that it knew would fail prematurely at a higher than acceptable rate, resulting in false claims to Medicare and Medicaid.
- Advertisement -
×